Providing solutions for your business is the founding goal of the Pfizer Injectables division of Pfizer Inc. Now, with the recent integration of King Pharmaceuticals, were poised to deliver far more comprehensive service capabilities, as well as a more robust product portfolio. By combining the cost-effectiveness of generic medicines with the resources of the worlds premier biopharmaceutical company, Pfizer Injectables can offer hands-on support to a broader range of health care professionals in the hospital setting.
At A Glance
Key therapeutic areas include: Anesthetics, Anticoagulants, Anti-infectives, Anti-inflammatories, Hemostatics, and Oncologics
Pfizer Injectables also has recently completed a series of strategic, niche-molecule acquisitions to further enhance our ability to fulfill your clinical practices needs. Our expansion over the first half of 2011 is just the latest example of our commitment to provide a growing portfolio of specialized products. With a focus on areas where quality and supply reliability are crucial and specialized technologies are required, Pfizer Injectables has identified the following therapeutic segments for expansion:
An inherent advantage of Pfizer Injectables is its ability to leverage the proven resources of Pfizer to execute at a high level of service and quickly respond to your needs with an expanded team of professionals across a broader range of constituencies. Were dedicated to responding to your hospitals needs with end-to-end, in-person servicefrom pharmacy to critical care units to surgical suites.
Pfizer Injectables provides a range of delivery options designed to help enhance safety and efficiency, such as:
In addition, our professionals continue to develop and introduce packaging innovations designed to help your professionals administer products more safely.
Launched in 2009, the Pfizer Injectables division continues to build on its Pfizer heritage. Behind our expanding portfolio of generic injectables and hospital products is a commitment to quality, reliable manufacturing, and customer-focused flexibility. Together, the professionals at Pfizer Injectables are dedicated to helping your business thrive by supplying and supporting medicines essential to the health and well-being of patients throughout the United States.
For full product listings, including the latest additions to our expanding generics line-up, visit www.pfizerinjectables.com.
ACT-O-VIAL is a registered trademark of Pfizer Inc, New York, N.Y.
ADD-Vantage is a registered trademark of Hospira Inc., Lake Forest, Ill.
CYTOSAFE is a registered trademark of Pfizer Inc, New York, N.Y.
Galaxy is a registered trademark of Baxter Healthcare Corporation, Round Lake, Ill.
This corporate profile was reviewed and approved by Pfizer Injectables.